A role of mTORC1 and RAS-ERK as well as Akt/PKB/ERK in TRPML1 (6, 60) and TRPML2-expressing tumor cells (12) has been proposed, although there are divergent findings in different cancer cell types. Here, MCOLN2 is linked to cancer.